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Objectives: Numerous studies have reported the epidemiological and clinical
features of Malta fever incidence in Iran. Review and synthesis of the related
literature through meta-analysis can provide an appropriate measurement for
aforementioned indices. Therefore, the present study aimed to determine the
epidemiological and clinical features of people with Malta fever in Iran.
Methods: The required documents were obtained through searching national and
international databases. In each study, standard deviation of the indices was
calculated using binomial distribution formulas. Finally, the heterogeneity index
was determined between studies using Cochran (Q) and I2 tests.
Results: Combining the results of 47 articles in the meta-analysis indicated that
57.6% (55.02e60.1%) and 42.3% (49.8e44.9%) of the patients were male and
female, respectively. Most of the patients lived in rural areas; 68.4% (63.6
e73.2%) compared to 31.4% (26.7e36.3%). In addition, 20.8% (17.4e24.2%) of the
patients were ranchers and farmers, 16.9% (14.5e19.4%) were students, and
31.6% (27e36.2%) were housewives. Of the patients studies, 50.5% (35.6e65.2%)
experienced contact with animals and 57.1% (46.4e67.9%) used unpasteurized
dairy products. Fever, joint pain, and sweating were detected among 65.7% (53.7
e77.8%) and 55.3% (44.4e66.2%), respectively.
Conclusion: The present study revealed that the frequency of male patients with
brucellosis was considerably more than that of female patients. The number of
patients with Malta fever in rural areas was significantly more than in urban
areas. High-risk behavior, unprotected contact with animals, and using unpas-
teurized dairy products were among the most significant factors affecting Malta
fever incidence in Iran. Fever, joint pain, and sweating were detected among
most of the patients with Malta fever.aeen).
ase Control and Prevention. Published by Elsevier Korea LLC. This is an open access article
reativecommons.org/licenses/by-nc-nd/4.0/).
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Brucellosis or Malta fever is a bacterial infection that
spreads from animals to humans. Despite the preventive
measurements adopted throughout the world; particu-
larly in the Mediterranean and Iran; the disease is still a
thread to public health [1,2]. Iran stands in the second
rank regarding the prevalence of Malta fever worldwide
[3]. Malta fever is caused by Brucella bacteria, partic-
ularly by Brucella melitensis, Brucella abortus, and
Brucella suis species. In advanced countries, men are
more affected compared with women. Children are more
affected than adults. In Iran and other areas, in which
brucellosis is endemic, there is no significant difference
between infection among children and adolescents.
Moreover, since Iranian rural women cooperate with
men in farming and animal husbandry, they are also
highly susceptible to the disease [4].
The clinical manifestations of people with brucellosis
include long-term fever, anorexia, fatigue, or involvement
of local organs such as arthritis [5]. Malta fever is trans-
mitted to humans through direct contact with animals or
through ingestion of infected dairy products. Therefore, it
is considered as an occupational hazard for people
involved in cattle-related jobs (e.g., veterinarians,
slaughterhouse workers, ranchers, and farmers) [2].
Different factors play a significant role in brucellosis
infection in humans. Direct and indirect contact including
using unpasteurized dairy products, animal husbandry,
and giving birth to ewes are significantly correlated with
the disease. Because of its long-lasting effects, Malta
fever is known as the disease of a thousand faces [6].
Therefore, identifying and controlling it play a crucial role
in improving public health [7]. Moreover, the wide
spectrum of brucellosis symptoms in human has led to the
fact that diagnosed people are considerably less than the
actual number of the infected population [8,9].
A database review indicates that numerous studies
are carried out on the epidemiological features of Malta
fever in Iran. An authentic measurement for the epide-
miological and clinical features of Malta fever can be
developed through combination of the research findings
using meta-analysis [10]. Furthermore, through sys-
tematic review and meta-analysis of the results, we can
provide well-grounded findings that can be used in
public health policy-making and proposing suggestions
for further research. The current research aimed to study
the epidemiological and clinical features, and high-risk
behaviors of people with Malta fever in Iran through
carrying out a meta-analysis.2. Materials and methods
2.1. Search strategy
Articles published in national and international jour-
nals, which were indexed in National Database, SID,Medlib, Magiran, Iranmedex, Scopus International
Database, Science Direct, PubMed, and Google Scholar,
were searched for relevant articles up to April 14, 2015.
The search was looking for Persian and English keywords
and the possible combination of important and sensitive
terms. The keywords included Malta Fever, Iran, human
brucellosis, brucellosis frequency, prevalence, epidemi-
ology, along with using “AND” and “OR” operators in
article subjects and abstracts. The Persian equivalents of
the words were also searched among published articles.
Some Persian databases were not sensitive to the opera-
tors, therefore, just Malta fever or brucellosis were
searched. To prevent missing any studies and to increase
the sensitivity, the references of the papers were also
checked. The search was evaluated and reviewed
randomly by two other researchers and the results indi-
cated that no article was missed. Furthermore, paper
databases were also searched for those articles that were
not published electronically. Experts in this field were
also consulted to find other unpublished works.
2.2. Study selection
Full text or abstracts, documents, and reports found in
advanced searches were extracted. After excluding du-
plicates, irrelevant articles were also excluded through
assessing titles, abstracts, and full texts, and finally the
relevant studies were selected. To avoid publication bias
(transverse and longitudinal), the studies were assessed
and duplicate papers were excluded.
2.3. Quality assessment
The quality of the relevant articles was evaluated
using the STROBE checklist (Strengthening the
Reporting of Observational Studies in Epidemiology)
[11] and another checklist used in a literature review
[12]. Items related to study type, sample size, research
objectives, population, inclusion and exclusion criteria
for primary research, analysis method, and appropriate
presentation of results were determined and a score was
assigned to each item. Those studies scoring  8 were
included in the research.
2.4. Data extraction
In each primary study, data were extracted based on
title, first author name, publication year, sample size, the
province in which the study was conducted, research
type, residency status, average age, occupation (rancher
and farmer, students, housewives), cattle contact history,
unpasteurized dairy product usage, and the most com-
mon clinical signs (fever, joint pain, and sweating). Data
were extracted by two researchers. We then examined
the level of agreement between the results obtained by
these two researchers.
2.5. Inclusion criteria
Persian and English studies with adequate sample
size on epidemiological and clinical features and high-
Epidemiology and clinical features of Malta fever 159risk behaviors of patients with Malta fever were selected
through the assessment procedure and scoring criteria.
2.6. Exclusion criteria
Studies that did not report the epidemiological and
clinical features of Malta fever, those with unknown
sample size, abstracts published in conference pro-
ceedings that did not include full text, and studies
published before 1990 were not included. Case reports,
caseecontrol studies, and studies that did not score the
minimum in quality assessment, were also excluded.
2.7. Statistical analysis
Stata version 11 (Stata version 11 Corporation, Col-
lege Station, TX, USA) software was used to analyze the
data. The standard error for frequency of epidemiolog-
ical features, high-risk behavior and, clinical signs of
people with Malta fever in each study was estimated
using binomial distribution formula. Finally, heteroge-
neity index between the studies was determined using
Cochran (Q) and I2 tests. Since the study incorporated
sources of heterogeneity, a random-effect model wasArticles screen
title & abstract (n
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Figure 1. Literature search and review floused to calculate the frequency of the epidemiological
features, high-risk behavior, and clinical signs of people
with Malta fever in Iran. Point estimation of the fre-
quency percentage of epidemiological features, high-
risk behavior, and clinical signs of people with Malta
fever in Iran were calculated in accumulation graph
(forest plots) with 95% confidence intervals.3. Results
A total of 4,247 articles were found through our
primary search in different databases, of which, 3,410
were excluded after narrowing the search results. Af-
terwards, the titles and abstracts of 837 primary studies
were checked, of which, 442 relevant articles remained
and 325 articles were excluded due to overlapping of
databases. Finally, 117 articles were selected. The ref-
erences were checked and four articles were found. Four
articles were found to be duplicated and were published
under two titles in different journals [4,13e19]. After
assessing the full text of articles and excluding theEliminated studies
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Table 1. Distribution of characteristics of primary studies included in meta-analysis.
Id
First author
(Ref)
Publication
year
Sample
size
Gender Area residence Job High Risk behavior Clinical sign Age
Male Female
Sex
ratio Urban Rural
Ranchers and
farmers Student Housewife
Animal
contact
Unpasteurized
dairy Fever
Joint
pain Sweating Average least high
1 Hasanzadeh [20] 2013 139 68.0 32.0 2.09 49.6 50.4 59.71 69.06 11e20
2 Almasi-Hashiani
[21]
2011 907 61.0 39.0 1.56 21.3 78.7 36.30 12.80 34.60 37.20
3 Haddadi [22] 2006 415 47.7 52.5 0.91 84.3 15.7 35.66 17.10 76.38 67.22 61.44 73.25 35.50 <20 20e40
4 Sharifi-Mood [23] 2007 181 53.0 47.0 1.13 24.6 75.4 38.0 4.00 29.0 50.00 43.0 39.00
5 Sahargahi [24] 2014 458 44.4 55.6 0.80 10.0 90.0 33.10 39.40 34.70
6 Ghasemi [25] 2003 1,591 51.5 48.5 1.06 22.0 78.0 16.50 19.50 41.70 10.60 36.70 15e19
7 Ayazi [16] 2012 175 61.0 39.0 1.56 43.0 57.0 50.00 58.00 65.0 78.00 22.50 44.0 <1 7e12
8 Eini [15] 2012 230 56.5 43.5 1.30 23.8 72.6 39.70 60.30 77.40 70.00 46.90 40.84 >80 21e60
9 Kassiri [4] 2013 43 65.1 34.9 1.87 17.1 82.9 20.90 6.70 30.20 20.90 79.10 33.34 0e4 15e24
10 Shoraka [7] 2010 64 68.8 31.2 2.20 9.4 90.6 12.50 15.60 26.60 82.80 23.40 62.50 56.20 32.80 30.70
11 Karami [26] 2009 194 45.0 55.0 0.83 37.0 63.0 17.53 16.49 39.69 60.00 40.00 70e79 10e29
12 Rajabzadeh [27] 2013 1,310 55.3 44.7 1.24 28.5 71.5 19.80 13.10 36.30 77.80 60.89
13 Golsha [28] 2011 77 74.0 26.0 2.85 27.8 72.2 27.20 53.30 83.10
14 Fallah [29] 1998 1,148 54.0 46.0 1.20 >50 <25
15 Afsharpaiman
[30]
2008 40 65.9 34.1 2.10 61.0 39.0 65.90 77.40 50.0 52.30 7.31
16 Beheshti [31] 2001 130 61.0 39.0 2.51 45.0 55.0 58.50 49.00 98.00 72.0 92.0 30.00
17 Bokaie [32] 2009 460 37.7 62.3 0.61 18.75 29.53 10e29
18 Mamishi [33] 2005 44 65.9 34.1 1.93 61.0 39.0 65.90 77.40 52.00 52.30 7.31
19 Bokaie [34] 2009 176 54.5 45.5 1.20 16.0 84.0 <19 20e40
20 Ebrahimpour
[35]
2012 377 54.4 45.6 1.19 25.7 74.3 5.57 18.22 40.31 23.07 <10 >50
21 Hosseini [36] 2009 115 68.7 32.2 2.11 34.80 13.90 23.50 80.90 89.60 86.10 77.40 73.90 29.40 <2 17e35
22 Farahani [37] 2011 3,880 60.0 40.0 1.50 28.0 72.0 >70 10e19
23 Bahador [38] 2012 40 52.5 47.5 1.11 47.50 100.0 40.00 >64 8e16
24 Kamran [39] 2011 126 57.9 42.1 1.38 27.0 73.0 37.70 40.50 13.50 41.29 50e59
25 Almasi [40] 2012 210 69.9 30.1 2.32 46.20 52.90 61.40 34.30 >60 15e30
26 Soleimani [41] 2012 5,732 54.9 45.1 1.22 14.4 85.6 80.00 86.40 30.90 <5 15e25
27 Ettehad [42] 2007 51 76.5 23.5 3.25 34.0 66.0 62.00 84.20 44.00 60.20 6.25
28 Soleimani [43] 2010 42 68.8 24.4 2.82 33.0 67.0 33.30 83.0 76.40 <5 10e15
29 Maleki [44] 2015 492 52.3 47.7 1.10 19.0 81.0 8.30 15.00 39.40 >70 25e30
30 Moradi [18] 2006 3,880 52.1 47.9 1.09 18.2 81.8 20.80 20.60 39.40 62.10 30.03 45e54 16e44
31 Zeinalian
Dastjerdi [45]
2012 1,996 32.8 67.2 0.49 32.0 68.0 18.10 15.20 25.70 15e20
32 Ghaffarpour [46] 2007 15 60.0 40.0 1.50 33.0 67.0 33.30 53.30 37.70
33 Haj Abdolbaghi
[47]
2001 505 63.6 36.4 1.74 59.5 40.5 34.25 66.70 65.0 10e20
34 Sasan [48] 2012 82 60.0 40.0 1.21 29.8 70.2 76.0 91.60 5.0 79.70 8.02
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Epidemiology and clinical features of Malta fever 161irrelevant ones, 58 studies were controlled through
assessment checklist and 11 articles were omitted.
Finally, 47 articles were selected (Figure 1).
In 47 studies selected for meta-analysis, we assessed
the epidemiological features of 31,572 patients with
Malta fever in Iran. Of 47 studies selected for this
structural review, 42 articles followed analy-
ticaledescriptive methods and the remaining five arti-
cles did not follow any specific method. The publication
year varied from 1998 to 2015 (Table 1).
Variables such as gender, residence, age, occupation,
high-risk behavior, and clinical signs were assessed.
Table 2 shows the frequency of the variables.
3.1. Gender
The gender distribution of patients with Malta fever
was reported in 46 articles, which demonstrated that
Malta fever in men varied from 32.8% (in Zeinalian
Dastjerdi et al’s [45] study) to 76.5% (in Ettehad et al’s
[42] study), and in women, it varied from 23.5% (in
Ettehad et al’s [42] study) to 67.2% (in Zeinalian
Dastjerdi et al’s [45] study). The ratio of male/female
patients with Malta fever in 41 of 47 studies was > 1
and it varied from 0.49 (in Zeinlian Dastjedri’s study) to
3.2 (in Ettehad et al’s [42] study). Using meta-analysis,
the frequency of Malta fever in men and women in Iran
was estimated to be 57.6% (55.02e60.1%) and 42.3%
(39.8e44.9%; Figures 2 and 3).
3.2. Residency
Thirty-six articles reported the residential status
(rural and urban) of people with Malta fever. The
prevalence of Malta fever in accordance with residential
status varied from 9.4% (in Shoraka et al’s [7] study) to
84.3% (In Haddadi et al’s [22] study) in urban areas and
15.7% (in Haddadi et al’s [22] study) to 90.6% (Shoraka
et al’s [7] study) in rural areas. The results of meta-
analysis demonstrated that 31.4% (26.7e36.3%) and
68.4% (63.6e73.2%) of patients with Malta fever in
Iran lived in urban and rural areas, respectively.
3.3. Age
The mean age of people with Malta fever was re-
ported in 26 studies, which varied from 6.25 years (in
Ettehad et al’s [42] study) to 41.29 years (in Kamran
et al’s [39] study). The 10e40 years age group was the
most frequent group with Malta fever in Iran. Age has
not been estimated by using meta-analysis so far. The
reason is that the standard error could not be calculated
as a result of information deficiency in primary studies.
3.4. Occupation
The frequency of Malta fever among ranchers and
farmers was reported in 24 studies, which varied from
4.8% (in Pourahmad et al’s [50] study) to 47.5% (in
Bahador et al’s [38] study). The frequency of Malta
fever among students was reported in 16 studies, which
Table 2. Estimation of frequency of brucellosis by epidemiological and clinical factors in Iran using meta-analysis.
Variables Frequency (95% CI)
Heterogeneity
Q I2 (%) p
Male 57.6 (55.02e60.1) 790.02 94.3 <0.001
Female 42.3 (39.8e44.9) 795.8 94.3 <0.001
Urban 31.4 (26.7e36.3) 3,308.9 98.9 <0.001
Rural 68.4 (63.6e73.2) 3,311.8 98.9 <0.001
Ranchers & farmers 20.8 (17.4e24.2) 740.4 96.9 <0.001
Students 16.9 (14.5e19.4) 210.5 92.9 <0.001
Housewife 31.6 (27e36.2) 862.2 97.6 <0.001
Animal contact 50.4 (35.6e65.2) 6,575.3 99.7 <0.001
Unpasteurized dairy 57.1 (46.4e67.9) 3,684 99.3 <0.001
Fever 65.7 (53.7e77.8) 2,832.04 99.2 <0.001
Joint pain 58.1 (49.5e66.6) 788.5 97.3 <0.001
sweating 55.3 (44.4e66.2) 849.6 98.1 <0.001
CI Z confidence limit.
162 M. Moosazadeh, et alvaried from 6.7% (in Kassiri et al’s [4] study) to 50% (in
Ayazi et al’s [16] study). The frequency of Malta fever
among housewives was reported in 22 studies, varying
from 4% (in Sharifi-Mood’s study) to 44.2% (in
Esmaeilnasab et al’s [56] study). The results of occu-
pation meta-analysis were as follows: 20.8%
(17.4e24.2%) of the patients with Malta fever in Iran
were ranchers and farmers; 16.9% (14.5e19.4%) were
students, and 31.6% (27e36.2%) were housewives.
3.5. High-risk behavior
Eighteen articles reported contact with animals and
breathing in barns and stable environments among pa-
tients with Malta fever, which varied from 10.6% (in
Ghasemi et al’s [25] study) to 82.8% (in Shoraka et al’s
[7] study). The results of meta-analysis indicated that
direct contact with animals in 50.4% (35.6e65.2%) of
patients was reported as the cause of the disease.
Twenty-six articles reported the frequency of using un-
pasteurized dairy products among patients with Malta
fever; the results of which varied from 22.4% (in
Hasanjani Roushan et al’s [49] study) to 100% (Bahador
et al’s [38] study). The results of meta-analysis indicated
that using unpasteurized dairy products was reported as
the cause of the disease in 57.1% (46.4e67.9%) of the
patients.
3.6. Clinical signs
Regarding the clinical signs, the frequency of fever
was reported in 23 studies, which varied from 5% (in
Sasan et al’s [48] study) to 98% (in Beheshti et al’s [31]
study). The frequency of joint pain was reported in 22
studies, which varied from 13.5% (in Kamran et al’s
[39] study) to 83% (in Soleimani et al’s [41] study). The
frequency of sweating was reported in 17 studies, which
varied from 18.4% (in Dehnavi et al [61]’s study) to
92% (in Beheshti et al’s [31] study). According to themeta-analysis results, the frequency of fever, joint pain
and sweating was 65.7% (53.7e77.8%) and 55.3%
(44.4e66.2%), respectively.4. Discussion
The current study investigated the epidemiology,
clinical features and high-risk behavior among patients
with Malta fever through a meta-analysis. The results
revealed that 57.6% of the patients were male and
42.3% were female, which is a significant difference due
to the 95% confidence interval and nonoverlapping. Of
the patients studied, 31.4% and 68.4% resided in urban
and rural areas, respectively, which was a significant
difference. With respect to occupation, about 21% of the
patients were ranchers and farmers, about 17% were
students, and 31.6% were housewives. About 50% of the
patients had contact with cattle and 57% used unpas-
teurized dairy products. Regarding the clinical signs,
58.1% of the patients had joint pain. Most of patients
were aged 10e40 years.
Malta fever is more prevalent in men than women,
therefore, gender is introduced as a risk factor in some
studies [5,62,63]. In a study conducted by Donev et al
[64], it was demonstrated that Malta fever was more
prevalent among villagers than people residing in urban
areas due to having contact with infected animals and
using unpasteurized products. A study conducted in
Saudi Arabia indicated that brucellosis in rural areas was
more prevalent as compared to urban areas [65].
Another study of Malta fever among children aged <
15 years in Jordan demonstrated that living in villages
increased the chance of being infected with brucellosis
[66].
The age range of patients with Malta fever in most
studies was consistent with our research [65,67e70]. In
Note: Weights are from random effects analysis
Overall  (I2 = 94.3%, p < 0.001)
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Figure 2. Pooled estimate of brucellosis prevalence in Iranian men.
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Note: Weights are from random effects analysis
Overall  (I2 = 94.3%, p < 0.001)
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Figure 3. Pooled estimate of brucellosis prevalence in Iranian women.
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Epidemiology and clinical features of Malta fever 165a study conducted by Mohammad Al-Sekait [71], high-
risk behavior, direct contact with infected cattle, and
using unpasteurized dairy products were considered as
the most important factors affecting Malta fever in
Madina. In a caseecontrol study in Yemen, Al-Shamahy
et al [72] reported that farmers and inhabitants who
consumed unpasteurized dairy products were more
affected with Malta fever than the control group. In yet
another study carried out in a province of Saudi Arabia,
the most infected occupational group included house-
wives, farmers, ranchers, and students [65]. Husseini
et al [6] found that Palestinian farmers were more sus-
ceptible to being infected with Malta fever as compared
with other occupations. The results of a study conducted
in Oman revealed that consuming infected milk and
contact with infected cattle were the main causes of
Malta fever [73]. In a study on inhabitants of eight
villages in Greece, it was demonstrated that using un-
pasteurized dairy products, being in the risky occupation
group (i.e., ranchers and slaughterhouse workers), and
having contact with infected animals were among the
factors leading to more cases of Malta fever [74]. A
study carried out in Northern Egypt reported that people
who had contact with animals were more susceptible to
Malta fever than those with no animal contact [70].
Earhart et al [75], in their study on Samarqand in
Uzbekistan, found that Malta fever was more prevalent
among people whom had more contact with cattle and
those who used more dairy products.
In a study conducted in Turkey, using unpasteurized
dairy products, raising cattle, and having risky occupa-
tions (veterinarians and butchers) were considered as
factors affecting Malta fever, and fever and joint pain
were reported as the most common symptoms of this
disease [76]. Other studies carried out in Turkey also
report fever, sweating, and joint pain as the most prev-
alent clinical signs [77,78]. In a systematic review study
conducted by Dean et al [79], it was indicated that fever,
sweating, and joint pain were the most prevalent
symptoms of Malta fever.
In Macedonia, Bosilkovski et al [80] found that most
people with Malta fever, had a history of direct animal
contact and suffered mostly from joint pain and
sweating.
Heterogeneity was a limitation of the current
research. To resolve this, the research used a random-
effect model. Another limitation was that epidemiolog-
ical features and high-risk behavior, such as article se-
lection criteria, were scattered and, therefore, they were
not measured comprehensively in all articles.
The present study revealed that the frequency of male
patients with brucellosis was considerably more than
female patients. The number of patients with brucellosis
in rural areas was significantly more than in urban areas.
Most patients were economically active in society.
High-risk behavior, unprotected contact with animals,
and using unpasteurized dairy products were among themost significant factors determining brucellosis infec-
tion in Iran. A high incidence of the disease in some
occupational groups, such as ranchers, farmers, and
housewives, and rural areas (compared to urban areas),
is probably due to the frequency of high-risk behavior.
Fever, joint pain, and sweating were detected among
most patients with Malta fever.Conflicts of interest
The authors declare that there was no conflict
interest.
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